View Cart

ICE Has Chilling Effect on Minnesota’s Medical Clinics

By Erik Goldman

Internist Matt Klein, MD, who is also a Minnesota state senator, speaking at a press conference in which dozens of clinicians described the dire impact of ICE’s “Operation Metro Surge” on healthcare in the Twin Cities and beyond.

Hundreds of Minnesota physicians are speaking out about the detrimental impact the recent Immigration and Customs Enforcement (ICE) actions have had on the state’s medical clinics.

“We are bearing witness to what fear can do to the health of a community,” writes internist Bernard E. Trappey, MD, on behalf of Minnesota Physicians Voices, in a letter to the New England Journal of Medicine, published January 29. Nearly 600 physicians, representing a wide range of specialties and care settings, signed the letter, which demands an end to ICE’s disruption of medical care in the state.

“In Minnesota, we have found ourselves in an extraordinarily dangerous time. As the presence here of Immigration and Customs Enforcement has increased, our clinic schedules have filled with missed appointments. Patient volumes have plummeted in our emergency departments (EDs),” says Trappey, an associate professor of medicine and pediatrics at the University of Minnesota.

[ ...Read More ]

Featured Articles

Pharma Pushes Back on State PFAS Regulations

Written by Claudia López Lloreda

In January 2025, Minnesota’s law regulating PFAS, a class of synthetic chemicals used to make products resistant to heat, grease, oil, and water, came into effect. The statute, one of the strongest of its kind in the United States, banned the chemicals across 11 categories, from cookware to textile furnishings. Beginning in July 2026, the […]

[ ...Read More ]

Required Reading on GLPs: Ashley Koff’s "Your Best Shot"

Written by Robert Bonakdar, MD, Contributing Writer

GLP-1–based therapies, including glucagon-like peptide-1 receptor agonists (e.g., semaglutide), dual incretin agonists (e.g. tirzepatide), and forthcoming GLP-1–modulating drugs like retatrutide, have rapidly reshaped the clinical management of obesity, type 2 diabetes, and cardiometabolic disease. In less than a decade, these drugs have moved from the weight management and endocrinology niches to much wider use in […]

[ ...Read More ]

HPC Video

Redox, Repair, and Resilience: Breaking the Sympathetic Spiral of Doom with Methylene Blue and GABA Modulation

Written by Erik Goldman

VIEW WEBINAR

Modern life keeps our foot glued to the sympathetic gas pedal—creating a spiral of stress, inflammation, and mitochondrial breakdown. In this free webinar, Dr. Scott Sherr explores how clinicians can break that “Sympathetic Spiral of Doom” by restoring mitochondrial redox balance with methylene blue and rebalancing the nervous system through targeted GABAergic modulation. 

We’ll examine methylene blue as both a redox cycler and mitochondrial rescue agent, reviewing evidence from models of ischemia, infection, and neuroinflammation. You’ll learn clinical indications and practical dosing strategies, as well as the safety considerations that separate high-quality pharma-grade methylene blue from contaminated or subtherapeutic versions commonly found online.

We’ll also connect the dots between mitochondrial dysfunction and GABA deficiency, and show how combining methylene blue with GABA orthosteric and allosteric ligands creates a synergistic, precisely dosed combination that rapidly restores balance between sympathetic overdrive and parasympathetic repair.

VIEW WEBINAR

Sponsored by

[ ...Read More ]

Latest News

Copyright © 2026 Holistic Primary Care. All Rights Reserved.